XVIVO PERFUSION AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 374 SEK | +4.91% |
|
+18.17% | +13.51% |
| Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
| Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Presenter SpeechDag Andersson;President&CEO (Executives)Good afternoon or good morning. Welcom...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Companyâs product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The Company markets its products in Europe, Asia, Middle East, and North & South America.
Calendar
2024-07-12
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
356.5
SEK
Average target price
402.2
SEK
Spread / Average Target
+12.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.51% | 1.03B | |
| -2.92% | 185B | |
| -3.80% | 105B | |
| -5.48% | 66.59B | |
| +11.22% | 54.66B | |
| +16.74% | 47.78B | |
| +4.06% | 41.26B | |
| +4.56% | 26.95B | |
| +1.64% | 26.37B | |
| +12.96% | 24.8B |
- Stock Market
- Equities
- XVIVO Stock
- News Xvivo Perfusion AB
- Transcript : Xvivo Perfusion AB - Analyst/Investor Day
